CN102861255A - 一种治疗流感的药物及其制剂的制备方法及质量控制方法 - Google Patents
一种治疗流感的药物及其制剂的制备方法及质量控制方法 Download PDFInfo
- Publication number
- CN102861255A CN102861255A CN2012103613179A CN201210361317A CN102861255A CN 102861255 A CN102861255 A CN 102861255A CN 2012103613179 A CN2012103613179 A CN 2012103613179A CN 201210361317 A CN201210361317 A CN 201210361317A CN 102861255 A CN102861255 A CN 102861255A
- Authority
- CN
- China
- Prior art keywords
- solution
- methanol
- adds
- preparation
- reference substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 206010022000 influenza Diseases 0.000 title claims abstract description 21
- 238000003908 quality control method Methods 0.000 title claims description 7
- 238000000034 method Methods 0.000 claims abstract description 59
- 229940079593 drug Drugs 0.000 claims abstract description 27
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 229930013930 alkaloid Natural products 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 162
- 239000000243 solution Substances 0.000 claims description 106
- 239000000341 volatile oil Substances 0.000 claims description 61
- 239000000284 extract Substances 0.000 claims description 54
- 238000012360 testing method Methods 0.000 claims description 54
- 239000000796 flavoring agent Substances 0.000 claims description 50
- 235000019634 flavors Nutrition 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 45
- 239000013558 reference substance Substances 0.000 claims description 39
- 239000012567 medical material Substances 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 31
- 239000000047 product Substances 0.000 claims description 31
- 239000012467 final product Substances 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 240000001312 Pecteilis susannae Species 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 16
- 239000011259 mixed solution Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 14
- 238000002347 injection Methods 0.000 claims description 14
- 239000007924 injection Substances 0.000 claims description 14
- 239000007921 spray Substances 0.000 claims description 14
- 229920000858 Cyclodextrin Polymers 0.000 claims description 13
- 239000001116 FEMA 4028 Substances 0.000 claims description 13
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 13
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 13
- 229960004853 betadex Drugs 0.000 claims description 13
- 239000003208 petroleum Substances 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 238000003556 assay Methods 0.000 claims description 11
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 235000012239 silicon dioxide Nutrition 0.000 claims description 11
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 claims description 10
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 claims description 10
- IAVUBSCVWHLRGE-UXEKTNMQSA-N (6e)-2,5-dihydroxy-6-[(e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C(C(O)([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C1=O)=O)=C(O)\C1=C(/O)\C=C\C1=CC=C(O)C=C1 IAVUBSCVWHLRGE-UXEKTNMQSA-N 0.000 claims description 9
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 claims description 9
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 229940039750 aconitine Drugs 0.000 claims description 9
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 9
- ZZMASNSDVDSYKO-UHFFFAOYSA-N hydroxysafflor yellow A Natural products OCC1OC(C(O)C(O)C1O)C2=C(O)C(O)(C3OC(CO)C(O)C(O)C3O)C(=O)C(=C2O)C(=O)C=Cc4ccc(O)cc4 ZZMASNSDVDSYKO-UHFFFAOYSA-N 0.000 claims description 9
- 238000004811 liquid chromatography Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 8
- 238000001256 steam distillation Methods 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- -1 ester alkaloid Chemical class 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- OYOSOPYTYFQFJM-UHFFFAOYSA-N CO.C(=O)OCC.C(Cl)(Cl)Cl Chemical compound CO.C(=O)OCC.C(Cl)(Cl)Cl OYOSOPYTYFQFJM-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 5
- 239000000446 fuel Substances 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004380 Cholic acid Substances 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- HTOBCWQYHHELFE-UHFFFAOYSA-N acetonitrile oxolane Chemical compound O1CCCC1.O1CCCC1.C(C)#N HTOBCWQYHHELFE-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 235000019257 ammonium acetate Nutrition 0.000 claims description 3
- 229930014669 anthocyanidin Natural products 0.000 claims description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims description 3
- 235000008758 anthocyanidins Nutrition 0.000 claims description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 3
- 235000019416 cholic acid Nutrition 0.000 claims description 3
- 229960002471 cholic acid Drugs 0.000 claims description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 3
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 3
- 235000012141 vanillin Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 abstract description 33
- 239000004615 ingredient Substances 0.000 abstract description 18
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 238000002407 reforming Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002481 ethanol extraction Methods 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 4
- 229940046011 buccal tablet Drugs 0.000 description 3
- 239000006189 buccal tablet Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000007922 dissolution test Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 229940123424 Neuraminidase inhibitor Drugs 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000002911 sialidase inhibitor Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Abstract
Description
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 15 | 85 |
60 | 35 | 65 |
提取方法 | 羟基红花黄色素A转移率(%) | 红景天苷转移率(%) |
水提取 | 85 | 87 |
30%乙醇提取 | 86 | 88 |
60%乙醇提取 | 88 | 90 |
制粒工艺 | 羟基红花黄色素A损失率(%) | 红景天苷损失率(%) |
一步制粒 | 1.2 | 2.0 |
湿法制粒 | 15.8 | 8.5 |
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 15 | 85 |
60 | 35 | 65 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210361317.9A CN102861255B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗流感的药物及其制剂的制备方法及质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210361317.9A CN102861255B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗流感的药物及其制剂的制备方法及质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102861255A true CN102861255A (zh) | 2013-01-09 |
CN102861255B CN102861255B (zh) | 2016-04-27 |
Family
ID=47440570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210361317.9A Active CN102861255B (zh) | 2012-09-26 | 2012-09-26 | 一种治疗流感的药物及其制剂的制备方法及质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102861255B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103585244A (zh) * | 2013-10-31 | 2014-02-19 | 济南星懿医药技术有限公司 | 一种丛菔提取物在制备治疗肺结核药物中的应用 |
CN104034841A (zh) * | 2014-06-23 | 2014-09-10 | 山东阿如拉药物研究开发有限公司 | 一种安儿宁颗粒的鉴别方法 |
CN104306366A (zh) * | 2014-10-22 | 2015-01-28 | 吉林大学 | 羟基红花黄色素在防治流感药物中的应用 |
CN107115301A (zh) * | 2017-05-27 | 2017-09-01 | 太极集团重庆桐君阁药厂有限公司 | 清骨散颗粒的制备方法及质量控制方法 |
CN116210901A (zh) * | 2023-01-09 | 2023-06-06 | 贵州医科大学 | 一种益气养血的保健品及制备方法和含量测定 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526536A (zh) * | 2012-03-14 | 2012-07-04 | 山东阿如拉药物研究开发有限公司 | 一种药物组合物安儿宁含片及其制备方法和应用 |
CN102590212A (zh) * | 2012-01-16 | 2012-07-18 | 西藏奇正藏药股份有限公司 | 九味竺黄制剂的检测方法 |
-
2012
- 2012-09-26 CN CN201210361317.9A patent/CN102861255B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102590212A (zh) * | 2012-01-16 | 2012-07-18 | 西藏奇正藏药股份有限公司 | 九味竺黄制剂的检测方法 |
CN102526536A (zh) * | 2012-03-14 | 2012-07-04 | 山东阿如拉药物研究开发有限公司 | 一种药物组合物安儿宁含片及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
骄阳出海: "九味竺黄散", 《百度百科》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103585244A (zh) * | 2013-10-31 | 2014-02-19 | 济南星懿医药技术有限公司 | 一种丛菔提取物在制备治疗肺结核药物中的应用 |
CN103585244B (zh) * | 2013-10-31 | 2015-12-09 | 于淑娟 | 一种丛菔提取物在制备治疗肺结核药物中的应用 |
CN104034841A (zh) * | 2014-06-23 | 2014-09-10 | 山东阿如拉药物研究开发有限公司 | 一种安儿宁颗粒的鉴别方法 |
CN104034841B (zh) * | 2014-06-23 | 2016-08-24 | 金诃藏药股份有限公司 | 一种安儿宁颗粒的鉴别方法 |
CN104306366A (zh) * | 2014-10-22 | 2015-01-28 | 吉林大学 | 羟基红花黄色素在防治流感药物中的应用 |
CN107115301A (zh) * | 2017-05-27 | 2017-09-01 | 太极集团重庆桐君阁药厂有限公司 | 清骨散颗粒的制备方法及质量控制方法 |
CN116210901A (zh) * | 2023-01-09 | 2023-06-06 | 贵州医科大学 | 一种益气养血的保健品及制备方法和含量测定 |
Also Published As
Publication number | Publication date |
---|---|
CN102861255B (zh) | 2016-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102123972B1 (ko) | 두통을 치료하기 위한 약학적 조성물 및 그의 제조방법 | |
CN100453106C (zh) | 一种治疗咽喉炎、扁桃体炎的中药复方制剂及其制备方法 | |
CN102861255B (zh) | 一种治疗流感的药物及其制剂的制备方法及质量控制方法 | |
CN111358839B (zh) | 头花蓼的配方颗粒和制备方法 | |
CN101569712B (zh) | 一种治疗感冒风寒的中药组合物 | |
CN101757099A (zh) | 金茵利胆药物及其制备方法和质量控制方法 | |
CN101829216B (zh) | 一种治疗支气管炎,支气管哮喘的中药制剂制备方法及检测方法 | |
CN102908519B (zh) | 一种治疗流感的药物及其制剂的制备方法及质量检测方法 | |
CN101195007B (zh) | 一种治疗感冒咳嗽的药物及其制剂的制备方法及质量控制方法 | |
CN105434511A (zh) | 一种雪胆饮片及其制备方法和用途 | |
CN109239239B (zh) | 清肺化痰止咳平喘的中药组合物及其制法和用途 | |
CN101816749A (zh) | 治疗癃闭的药物及其制法和质量控制方法 | |
CN107802678A (zh) | 一种喉康散的制备方法 | |
CN104524273A (zh) | 一种银翘制剂的制备方法 | |
CN101670088B (zh) | 一种治疗急、慢性支气管炎的中药组合物 | |
CN102631386B (zh) | 柴胡解热镇痛制剂及其制备工艺 | |
CN106309554A (zh) | 一种用于预防和/或治疗口腔溃疡的黄芩提取物及其药物组合物 | |
CN111249421B (zh) | 一种治疗湿热性外感热病初起的中药制剂及其制备方法和用途 | |
CN111588771B (zh) | 一种中药组合物在制备用于眩晕症药物中的应用 | |
CN109432193B (zh) | 一种治疗咳嗽的药物组合物及其制备方法 | |
CN103110890A (zh) | 协日嘎四味有效部位及其制备方法、质量检测方法和应用 | |
CN109157632B (zh) | 一种治疗胃脘痛颗粒剂配方及制备方法 | |
CN101485817B (zh) | 治疗梅毒感染的中药组合物及其制备方法和质量控制方法 | |
CN110585405B (zh) | 一种止咳平喘的中药组合物 | |
CN102861142B (zh) | 一种治疗肺炎的药物及其制剂的制备方法及质量控制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Kong Qianqian Inventor after: Zhang Xinfang Inventor after: Pang Dakun Inventor before: Kong Qianqian Inventor before: Shao Chengming Inventor before: Pang Dakun |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200108 Address after: Room 1312, main building, scientific research center, biomedical park, No.1, Lutai Avenue, high tech Zone, Zibo City, Shandong Province Patentee after: Wuyuan Bencao (Shandong) Health Technology Co., Ltd Address before: 250101 No. 51 Industrial South Road, Shandong, Ji'nan Patentee before: Jinan Xingyi Medical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211210 Address after: 250100 No. 51, Gongye South Road, high tech Zone, Jinan City, Shandong Province Patentee after: JINAN HAOYU QINGTIAN MEDICINE TECHNOLOGY Co.,Ltd. Address before: 255000 room 1312, main building, scientific research center, biomedical park, No. 1, Lutai Avenue, high tech Zone, Zibo City, Shandong Province Patentee before: Wuyuan Bencao (Shandong) Health Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220602 Address after: 255000 room 1312, main building, scientific research center, biomedical park, No. 1, Lutai Avenue, high tech Zone, Zibo City, Shandong Province Patentee after: Wuyuan Bencao (Shandong) Health Technology Co.,Ltd. Address before: 250100 No. 51, Gongye South Road, high tech Zone, Jinan City, Shandong Province Patentee before: JINAN HAOYU QINGTIAN MEDICINE TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |